IP Library Granted Patent US 12,005,096
Granted Patent B2
US 12,005,096 · App. 17/119,075 · Granted Jun 11, 2024

Apoaequorin and vitamin d-containing compositions and methods of using same

Inventor: Mark Y. Underwood (Madison, WI)
Assignee: Quincy Bioscience, LLC
A61K38/1767A23L33/155A23L33/17A61K9/48A61K31/593
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,005,096
App. No.
17/119,075
Granted
Jun 11, 2024
Kind
B2
Abstract

Compositions containing apoaequorin and vitamin D and methods for their use in treating symptoms and disorders related to calcium imbalances and vitamin D deficiency associated with, for example, sleep quality, energy quality, mood quality, memory quality or pain are provided by the present invention.

Claims (17)

1. A composition for treating a symptom or disorder related to cell death following ischemia comprising:

(a) a therapeutically effective amount of apoaequorin;

(b) a therapeutically effective amount of vitamin D; and

(c) an acceptable carrier

wherein the therapeutically effective amount of apoaequorin is about 10 mg to 50 mg and the therapeutically effective amount of vitamin D is about 25 mcg to about 75 mcg.

2. The composition according to claim 1 , wherein the composition is in the form of a unit dosage containing said effective amounts of the apoaequorin and vitamin D.

3. The composition according to claim 2 , wherein: (a) the effective amount of apoaequorin in the unit dosage is about 20 mg; and (b) the effective amount of vitamin D in the unit dosage is about 50 mcg.

4. The composition according to claim 1 , wherein the vitamin D is in the form of D3 cholecalciferol.

5. The composition according to claim 1 , wherein the unit dosage is a capsule.

6. The composition according to claim 1 , wherein the composition is a nutraceutical composition.

7. A method of administering a composition comprising

administering to a subject an effective amount of the composition of claim 1 .

8. The method according to claim 7 , wherein administration of the composition to said subject improves sleep quality in the subject.

9. The method according to claim 7 , wherein administration of the composition to said subject improves energy quality in the subject.

10. The method according to claim 7 , wherein administration of the composition to said subject improves mood quality in the subject.

11. The method according to claim 7 , wherein administration of the composition to said subject alleviates pain in the subject.

12. The method according to claim 7 , administration of the composition to said subject improves memory quality in the subject.

Assignments (1)
SECURITY INTEREST Recorded Oct 18, 2024
From: QUINCY BIOSCIENCE, LLC
To: TRUIST BANK
Reel/Frame 068938/0846 →
Continuity (3)
Continuation 16336016
Provisional Application 62398669 · Sep 23, 2016
Related Publication 20210169981A1 · Jun 10, 2021